Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor

ABSTRACT The intestinal microbiome influences growth and disease progression in children with cystic fibrosis (CF). Elexacaftor-tezacaftor-ivacaftor (ELX/TEZ/IVA), the newest pharmaceutical modulator for CF, restores the function of the pathogenic mutated CF transmembrane conductance regulator (CFTR...

Cijeli opis

Bibliografski detalji

Glavni autori:	Seth A. Reasoner, Rachel Bernard, Adam Waalkes, Kelsi Penewit, Janessa Lewis, Andrew G. Sokolow, Rebekah F. Brown, Kathryn M. Edwards, Stephen J. Salipante, Maria Hadjifrangiskou, Maribeth R. Nicholson
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology 2024-02-01
Serija:	mBio
Teme:	cystic fibrosis CFTR modulator microbiome elexacaftor ivacaftor tezacaftor
Online pristup:	https://journals.asm.org/doi/10.1128/mbio.01935-23
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!